Yankton Medical Clinic Issues Clinical Advisory Following First Measles Case Reported in South Dakota
The South Dakota Department of Health has confirmed the first laboratory-confirmed measles case in the state this year. The case involves an adult patient in Meade County who developed the illness following international travel. In response, Yankton Medical Clinic, P.C. is issuing clinical guidance regarding measles surveillance, patient assessment, and vaccination protocols for this highly contagious viral disease.
According to the Centers for Disease Control and Prevention (CDC), measles presents significant clinical risks, particularly in pediatric patients under five years of age. The MMR (measles, mumps, and rubella) vaccine remains the primary prophylactic intervention. The CDC states:
"Some people think of measles as just a little rash and fever that clears up in a few days. But measles can cause serious health complications, especially in children younger than 5 years old. If one person has it, up to 9 out of 10 people nearby will become infected if they are not protected. The MMR vaccine provides long-lasting protection against all strains of measles."
Clinical Presentation of Measles:
High fever (may spike above 104°F)
Cough
Runny nose (coryza)
Red, watery eyes (conjunctivitis)
Rash, beginning on the face and spreading to the rest of the body
Symptom onset typically occurs 7 to 14 days post-exposure. The South Dakota Department of Health reports that the clinical course often progresses in two distinct phases. Prodromal symptoms include coryza, cough, mild fever, and photophobia. Disease progression involves high fever (103–105°F) and the characteristic erythematous, maculopapular rash lasting 4–7 days.
"Measles is a highly contagious viral disease and spreads through the air from an infected person," said Dr. Joshua Clayton, South Dakota State Epidemiologist. "Individuals without immunity—either through vaccination or past infection—are at high risk."
Clinical Criteria for Measles Immunity:
According to the South Dakota Department of Health, patients are generally considered immune if they meet one of the following clinical criteria:
Born before 1957
Received one dose of MMR vaccine (adults)
Received two doses of MMR vaccine (children or high-risk adults)
Laboratory evidence of measles antibodies
History of measles confirmed by laboratory testing
Standard MMR vaccination protocol includes two doses: the first at 12–15 months and the second at 4–6 years of age. For international travelers, infants as young as six months may require early vaccination consideration.